Anzeige
Mehr »
Login
Mittwoch, 02.04.2025 Börsentäglich über 12.000 News von 695 internationalen Medien
Der CEO kauft ein - und das gleich zweimal: Startschuss für die nächste Kursrallye?
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

Medien-Archiv vom 06.12.2024

ZeitNachrichten
Sprache: Alle DE EN
LeserMedien
06.12.24Nasdaq Stockholm AB: Listing of Intea Fastigheter AB (publ) on Nasdaq Stockholm113Nasdaq Stockholm AB has assessed that Intea Fastigheter AB (publ), company registration number 559027-5656, fulfills Nasdaq Stockholm's listing requirements. Provided that Intea Fastigheter AB (publ)...
► Artikel lesen
06.12.24Nasdaq Stockholm AB: Reverse Split and Change of ISIN for Tangiamo Touch Technology AB210Referring to the press release from Tangiamo Touch Technology AB from December 5, 2024, the company will carry out a reverse stock split in relations 1:1000. The share will be traded under new ISIN...
► Artikel lesen
06.12.24Nasdaq Vilnius welcomes Kalve Coffee to the Baltic First North Market123Riga/Tallinn/Vilnius, Nasdaq Baltic Market, December 6, 2024 - Nasdaq (NDAQ) announces that the shares of Kalve Coffee (ticker: KALVE) have been listed on the Nasdaq Baltic First North Market by...
► Artikel lesen
06.12.24Nickel Creek Platinum Corp.: Nickel Creek Announces TSX-V Listing And Voluntary Delisting From TSX And Departure Of A Director115OAKVILLE, ON, Dec. 6, 2024 /CNW/ - Nickel Creek Platinum Corp. (TSX: NCP) ("Nickel Creek" or the "Company") announces that it has received conditional approval...
► Artikel lesen
06.12.24Nasdaq Stockholm welcomes Apotea to the Main Market381Stockholm, Dec 6, 2024 - Nasdaq (Nasdaq: NDAQ) announces that trading in the shares of Apotea AB (ticker name: APOTEA) will commence today on the Nasdaq Stockholm Main Market. Apotea is a mid-cap...
► Artikel lesen
06.12.24NYSE American to Commence Delisting Proceedings Against Golden Minerals Company (AUMN)101NEW YORK--(BUSINESS WIRE)--NYSE American LLC ("NYSE American" or the "Exchange") announced today that the staff of NYSE Regulation has determined to commence proceedings to delist the common stock...
► Artikel lesen
06.12.24ENR Russia Invest SA: Results of the extraordinary general meeting132AD HOC ANNOUNCEMENT PURSUANT TO ART. 53 LR Geneva, 6 December 2024 Results of the ENR Russia Invest SA extraordinary general meeting All motions proposed by the board of directors ("Board")...
► Artikel lesen
06.12.24Covenant Logistics Group, Inc.: Covenant Logistics Group Announces Two-For-One Stock Split284CHATTANOOGA, Tenn., Dec. 06, 2024 (GLOBE NEWSWIRE) -- Covenant Logistics Group, Inc. (NYSE: CVLG) ("Covenant" or the "Company") announced today that its board of directors has declared a two-for-one...
► Artikel lesen
06.12.24Athira Pharma, Inc.: Athira Pharma Presents Preclinical Data Highlighting Neuroprotective Effects of ATH-1105 in Models of ALS at Motor Neurone Disease Association's 35th International Symposium on ALS/MND270BOTHELL, Wash., Dec. 06, 2024 (GLOBE NEWSWIRE) -- Athira Pharma, Inc. (NASDAQ: ATHA), a clinical-stage biopharmaceutical company focused on developing small molecules to restore neuronal health and...
► Artikel lesen
06.12.24Zevra Therapeutics Announces Organizational Changes221CELEBRATION, Fla., Dec. 06, 2024 (GLOBE NEWSWIRE) -- Zevra Therapeutics, Inc. (NasdaqGS: ZVRA) (Zevra, or the Company), a commercial-stage company focused on addressing unmet needs for the treatment...
► Artikel lesen
06.12.24BioAge Labs, Inc.: BioAge Labs Announces Discontinuation of STRIDES Phase 2 Clinical Trial Evaluating Azelaprag in Combination with Tirzepatide for the Treatment of Obesity215Decision follows observations of liver transaminitis without clinically significant symptoms in some subjects on azelaprag Company will evaluate data from patients enrolled to date and share updated...
► Artikel lesen
06.12.24Cerence AI Announces Equity Grant to Employee Under Inducement Plan Pursuant to Nasdaq Listing Rule 5635(c)(4)298BURLINGTON, Mass., Dec. 06, 2024 (GLOBE NEWSWIRE) -- Cerence Inc. (NASDAQ: CRNC) ("Cerence AI"), a global industry leader in AI for transportation, today announced that, in connection with Antonio...
► Artikel lesen
06.12.24Tempest Therapeutics: Tempest Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)322BRISBANE, Calif., Dec. 06, 2024 (GLOBE NEWSWIRE) -- Tempest Therapeutics, Inc. (Nasdaq: TPST), a clinical-stage biotechnology company developing first-in-class1 targeted and immune-mediated therapeutics...
► Artikel lesen
06.12.24Osisko Metals Incorporated: Osisko Metals Acquires Additional Claims Near Gaspé Copper206MONTREAL, Dec. 06, 2024 (GLOBE NEWSWIRE) -- Osisko Metals Incorporated (the "Company or "Osisko Metals") (TSX-V: OM; OTCQX: OMZNF; FRANKFURT: 0B51) is pleased to announce the acquisition of a group...
► Artikel lesen
06.12.24Dynamix Corporation Announces the Separate Trading of its Class A ordinary shares and Warrants Commencing December 9, 2024150Houston, TX, Dec. 06, 2024 (GLOBE NEWSWIRE) -- Dynamix Corporation (the "Company") today announced that commencing December 9, 2024, holders of the units sold in the Company's initial public offering...
► Artikel lesen
06.12.24Freight App, Inc.: Freight Technologies Provides Update on its Public Filings Procedures250HOUSTON, Dec. 06, 2024 (GLOBE NEWSWIRE) -- Freight Technologies, Inc. (Nasdaq: FRGT, "Fr8Tech" or the "Company"), a logistics management innovation company, offering a diverse portfolio of technology-driven...
► Artikel lesen
06.12.24Codexis, Inc.: Codexis Announces New Employment Inducement Grants216REDWOOD CITY, Calif., Dec. 06, 2024 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ: CDXS), a leading provider of enzymatic solutions for efficient and scalable therapeutics manufacturing, today announced...
► Artikel lesen
06.12.24Apellis Pharmaceuticals, Inc.: Apellis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)209WALTHAM Mass., Dec. 06, 2024 (GLOBE NEWSWIRE) -- Apellis Pharmaceuticals, Inc. (Nasdaq: APLS), a global biopharmaceutical company and leader in complement, today announced that the company approved...
► Artikel lesen
06.12.24Adverum Biotechnologies, Inc.: Adverum Biotechnologies Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)162REDWOOD CITY, Calif., Dec. 06, 2024 (GLOBE NEWSWIRE) -- Adverum Biotechnologies, Inc. (Nasdaq: ADVM) today announced that on December 4, 2024, the Compensation Committee of Adverum's Board of Directors...
► Artikel lesen
06.12.24NurExone Biologic Inc: NurExone Announces Promising Preclinical Results in Restoring Vision After Optic Nerve Damage300TORONTO and HAIFA, Israel, Dec. 06, 2024 (GLOBE NEWSWIRE) -- NurExone Biologic Inc. (TSXV: NRX), (OTCQB: NRXBF), (Germany: J90) ("NurExone" or the "Company"), a biopharmaceutical company developing...
► Artikel lesen
Seite:  Weiter >>
Suchbegriffe der letzen 24 hAnzahl
TESLA3.849
NVIDIA3.309
THYSSENKRUPP2.562
RENK GROUP2.364
STEYR MOTORS2.215
DEUTZ2.129
BYD2.105
RHEINMETALL2.081
NEL2.042
BAYER1.866
XIAOMI1.597
TUI1.591
NOVO NORDISK1.452
EVOTEC1.294
COMMERZBANK1.065
VOLKSWAGEN1.052
MERCEDES-BENZ958
DEUTSCHE BANK955
MUTARES920
AIXTRON SE882
NORDEX861
PORSCHE AG856
BASF822
PUMA788
RWE752